| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
|
Zhou, Jie
|
|
|
12 |
4 |
p. 1652-1661
|
artikel
|
| 2 |
Analysis of new drug registration and review in China in 2021
|
Hu, Hongxi
|
|
|
12 |
4 |
p. 2127-2128
|
artikel
|
| 3 |
Approved HIV reverse transcriptase inhibitors in the past decade
|
Li, Guangdi
|
|
|
12 |
4 |
p. 1567-1590
|
artikel
|
| 4 |
A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes
|
Feng, Lei
|
|
|
12 |
4 |
p. 1976-1986
|
artikel
|
| 5 |
Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
|
Shao, Xuejing
|
|
|
12 |
4 |
p. 1856-1870
|
artikel
|
| 6 |
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
|
Yao, Yongrong
|
|
|
12 |
4 |
p. 2103-2119
|
artikel
|
| 7 |
Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy
|
Yang, Chuanbin
|
|
|
12 |
4 |
p. 1707-1722
|
artikel
|
| 8 |
Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement
|
Pan, Zhidi
|
|
|
12 |
4 |
p. 1928-1942
|
artikel
|
| 9 |
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
|
Hou, Lingxin
|
|
|
12 |
4 |
p. 1805-1824
|
artikel
|
| 10 |
Cover Story
|
|
|
|
12 |
4 |
p. xv
|
artikel
|
| 11 |
Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination
|
Xiao, Zhiwei
|
|
|
12 |
4 |
p. 1963-1975
|
artikel
|
| 12 |
Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1H-pyrazol-4-yl) amino) quinazolin-6-yl)-N-(3-(trifluoromethyl) phenyl) benzamides as potent discoidin domain receptor inhibitors for the treatment of idiopathic pulmonary fibrosis
|
Wang, Qi
|
|
|
12 |
4 |
p. 1943-1962
|
artikel
|
| 13 |
Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)
|
Senaweera, Sameera
|
|
|
12 |
4 |
p. 1671-1684
|
artikel
|
| 14 |
Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation
|
Wang, Pengcheng
|
|
|
12 |
4 |
p. 1899-1912
|
artikel
|
| 15 |
Editorial of Special Column on Antiviral Drug Discovery and Pharmacology
|
Wang, Jun
|
|
|
12 |
4 |
p. 1540-1541
|
artikel
|
| 16 |
Editorial of special column on Drug targets and drug development for Alzheimer's disease
|
Ding, Wen-Xing
|
|
|
12 |
4 |
p. 1686-1687
|
artikel
|
| 17 |
Editor Profiles: Guest Editors of Special Column on Antiviral Drug Discovery and Pharmacology
|
|
|
|
12 |
4 |
p. 1539
|
artikel
|
| 18 |
Engineered platelets-based drug delivery platform for targeted thrombolysis
|
Wang, Songli
|
|
|
12 |
4 |
p. 2000-2013
|
artikel
|
| 19 |
Enterovirus A71 antivirals: Past, present, and future
|
Wang, Jun
|
|
|
12 |
4 |
p. 1542-1566
|
artikel
|
| 20 |
Guest Editors of Special Column on Drug Targets and Drug Development for Alzheimer’s Disease
|
|
|
|
12 |
4 |
p. 1685
|
artikel
|
| 21 |
High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS
|
Guo, Minsong
|
|
|
12 |
4 |
p. 1723-1739
|
artikel
|
| 22 |
Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection
|
He, Xueqin
|
|
|
12 |
4 |
p. 1987-1999
|
artikel
|
| 23 |
In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus
|
Li, Zhong
|
|
|
12 |
4 |
p. 1662-1670
|
artikel
|
| 24 |
Milk-derived exosomes exhibit versatile effects for improved oral drug delivery
|
Wu, Lei
|
|
|
12 |
4 |
p. 2029-2042
|
artikel
|
| 25 |
Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases
|
Fu, Minyang
|
|
|
12 |
4 |
p. 1740-1760
|
artikel
|
| 26 |
Multiparametric characterization of red blood cell physiology after hypotonic dialysis based drug encapsulation process
|
Robert, Mélanie
|
|
|
12 |
4 |
p. 2089-2102
|
artikel
|
| 27 |
Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance
|
Wang, Hong
|
|
|
12 |
4 |
p. 1871-1884
|
artikel
|
| 28 |
Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques
|
Xu, Mengqi
|
|
|
12 |
4 |
p. 2014-2028
|
artikel
|
| 29 |
Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
|
Deng, Zhiqiang
|
|
|
12 |
4 |
p. 1688-1706
|
artikel
|
| 30 |
PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia
|
Tsai, Hsiang-i
|
|
|
12 |
4 |
p. 1913-1927
|
artikel
|
| 31 |
“Pincer movement”: Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles
|
Niu, Boyi
|
|
|
12 |
4 |
p. 2074-2088
|
artikel
|
| 32 |
Prmt1 upregulated by Hdc deficiency aggravates acute myocardial infarction via NETosis
|
Zhang, Zhiwei
|
|
|
12 |
4 |
p. 1840-1855
|
artikel
|
| 33 |
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
|
Xiang, Rong
|
|
|
12 |
4 |
p. 1591-1623
|
artikel
|
| 34 |
Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
|
He, Yang
|
|
|
12 |
4 |
p. 2057-2073
|
artikel
|
| 35 |
Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury
|
Xue, Tengfei
|
|
|
12 |
4 |
p. 1885-1898
|
artikel
|
| 36 |
Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2
|
Aliyari, Saba R.
|
|
|
12 |
4 |
p. 1624-1635
|
artikel
|
| 37 |
Table of Contents
|
|
|
|
12 |
4 |
p. iii-xiv
|
artikel
|
| 38 |
Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
|
Shan, Yunlong
|
|
|
12 |
4 |
p. 1825-1839
|
artikel
|
| 39 |
The effect of drug loading and multiple administration on the protein corona formation and brain delivery property of PEG-PLA nanoparticles
|
Tang, Yuyun
|
|
|
12 |
4 |
p. 2043-2056
|
artikel
|
| 40 |
Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
|
Liu, Hui
|
|
|
12 |
4 |
p. 1781-1804
|
artikel
|
| 41 |
The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies
|
Zhong, Tiecheng
|
|
|
12 |
4 |
p. 1761-1780
|
artikel
|
| 42 |
Unraveling the drug distribution in brain enabled by MALDI MS imaging with laser-assisted chemical transfer
|
Guo, Shuai
|
|
|
12 |
4 |
p. 2120-2126
|
artikel
|
| 43 |
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
|
Ma, Chunlong
|
|
|
12 |
4 |
p. 1636-1651
|
artikel
|
Tijdschrift beschrijving